Literature DB >> 36129928

Living with a left ventricular assist device: Capturing recipients experiences using group concept mapping software.

Anita L Slade1,2,3,4, Margaret E O'Hara5,6, David Quinn5, Laura Marley5, Stephen Griffith1,7, Melanie Calvert1,2,3,4,8, M Sayeed Haque9, Hoong Sern Lim5, Philippa Doherty5, Deirdre A Lane10,11.   

Abstract

BACKGROUND: Left ventricular assist device (LVAD) implantation significantly impacts on a recipient's symptoms and quality of life. Capturing their experiences and post implant journey is an important part of clinical practice, research and device design evolution. Patient reported outcome measures (PROMs) are a useful tool for capturing that experience. However, patient reported outcome measures need to reflect recipients' experiences. Discussions with a patient partner group found that none of the frequently used cardiology PROMs captured their unique experiences. AIMS: To capture the experiences and important issues for LVAD recipients. Develop a conceptual map of domains and items that should be reflected in patient reported outcomes.
METHODS: Group concept mapping (GCM) web-based software was used to remotely capture and structure recipients' experiences across a wide geographical area. GCM is a semi-quantitative mixed method consisting of 3 stages: item generation, item sorting and rating (importance, relevance and frequency). Patient partners were involved in all aspects of the study design and development.
RESULTS: 18 LVAD recipients consented to take part. 101 statements were generated and multi-dimensional scaling, and hierarchical cluster analysis identified 9 clusters. Cluster themes included: Activities, Partner/family support, Travel, Mental wellbeing, Equipment and clothing, Physical and cognitive limitations, LVAD Restrictions, LVAD Challenges and positive impact of the LVAD (LVAD Positives). LVAD Positives were scored highest across all the rating variables, e.g., frequency (2.85), relevance (2.44) and importance (2.21). Other domains rated high for importance included physical and cognitive limitations (2.19), LVAD restrictions (2.11), Partner/family support (2.02), and Equipment and clothing (2.01).
CONCLUSION: Online GCM software facilitated the inclusion of geographically dispersed recipients and provided useful insights into the experiences of LVAD recipients. The conceptual framework identifies important domains and items that should be prioritised and included in patient reported outcomes in future research, LVAD design evolution, and clinical practice.

Entities:  

Mesh:

Year:  2022        PMID: 36129928      PMCID: PMC9491568          DOI: 10.1371/journal.pone.0273108

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.752


Background

Globally, the number of people living with heart failure is increasing, currently affecting approximately 26 million people [1]. Advanced heart failure is associated with high mortality rates (50% at 1 year), and a disease burden similar to other chronic diseases [2, 3]. Heart transplantation offers good long term outcomes, but donor shortages limit this therapy to a minority of potential recipients [4]. A left ventricular assist device (LVAD) is one therapeutic option, offered to patients who are eligible for heart transplantation in the UK [5]. However, in the absence of LVAD-related complications, LVAD recipients then join the low priority routine transplant waiting list. As a result, most uncomplicated LVAD recipients live with LVAD therapy for years, akin to so-called “destination therapy” [6]. While many recipients experience an improvement in their symptoms and health related quality of life (HRQoL), LVAD implantation is associated with mortality risks and serious adverse events such as stroke, right ventricular failure, device related infections, and bleeding [4, 7]. Receiving an LVAD also requires substantial lifestyle changes and adaptation, and can cause psychological and social difficulties for the recipient and their families [8, 9]. Managing these issues requires ongoing clinical intervention and support. Anticipation of adverse events and better understanding of the patient journey after implantation may help prevent some of the issues that arise post implant. One study comparing the impact of two LVAD designs on survival and incidence of stroke at two years found significant differences between devices [7]. Therefore, device design evolutions also need to address recipients’ and clinicians concerns by demonstrating that they improve HRQoL as well as reducing adverse events or complications for recipients. Monitoring potential HRQoL changes requires measurement instruments to be sensitive and relevant. Patient reported outcome measures (PROMs) are one way of capturing a recipient’s journey, and the impact of the LVAD on their HRQoL [10]. PROMs are self-reported questionnaires that evaluate a person’s health and HRQoL from their perspective. Research has shown that utilizing PROMs as part of a clinical consultation can improve the dialogue between clinicians and patients, enabling timely clinical interventions, and better utilisation of clinical resources [11-13]. Using PROMs can also improve patient outcomes by identifying potential adverse events, reducing side effects, and improving survival rates [12, 14, 15]. For PROMs to be effective measurement tools they need to be sensitive and reflective of the issues important to the clinical population. Studies have demonstrated that PROMs developed with input from people with lived experience of the health condition are more sensitive and have superior content validity [16-18]. It is important that PROMs used with LVAD recipients should be underpinned by a conceptual framework supporting content validity and reflecting their important key domains [19, 20]. This approach is supported by the European Medical Agency and the U.S. Food and Drug Administration (FDA). Current FDA guidelines require evidence of this approach when using PROMs to support labelling claims for therapeutics and medical devices [18, 20, 21]. However, a review of PROMs currently used in chronic heart failure and mapped against FDA guideline criteria found they were unsuitable for supporting labelling claims [22]. A systematic review also found few studies where PROMS were developed with LVAD recipient input or addressing their psychological issues [23]. These deficiencies were supported by our discussions with LVAD recipients as part of a public and patient involvement (PPI) group [24]. The group suggested that many of the symptoms captured by cardiac-specific measures were no longer relevant to them. Other generic PROMs did not address some of the unique and problematic aspects of their lives, such as dealing with the LVAD equipment and restrictions, psychological impacts, and side effects. The consensus was that these unique issues need to be addressed by a PROM which reflected their experiences. Therefore, the objectives of this current study were: (1) identify the lived experience of LVAD recipients and the impact of living with an LVAD on HRQoL; (2) identify the range of issues, domains and items that were most important to LVAD recipients and (3) improve research and clinical practice by ensuring LVAD recipient voices were reflected in any PROMS used in clinical consultations, research, and LVAD design evolution.

Methods

Recruitment

Participants were recruited from one of the UK’s national heart transplant centres covering a wide cohort of ethnic groups, and a large geographical area incorporating urban and rural areas. Consent to contact was obtained from the LVAD co-ordinators during routine clinical appointments. Electronic or hard copies of the patient information sheets, demographic questionnaire and consent forms were then sent to the recipient by the research team (based on patient preference). Written or electronic consent was obtained depending on participants preferences for contact. Ethical approval was given by the NHS Health Research Authority (Ref No. 19/WM/0120). Inclusion criteria were all current or previous LVAD recipients aged ≥18 years with access to the internet. Patients with insufficient English, severe communication problems, terminally ill or with severe cognitive or mental health problems were excluded. Participants unable to access the internet were offered the chance to participate in future qualitative interviews. During routine clinical appointments, patients who met the inclusion criteria were approached by LVAD coordinators and if interested in the project, signed a consent-to-contact form. This was sent to the research team, and depending on their preference, electronic or hard copies of the participant information sheet, consent form, and demographic questionnaire were sent to patients.

Group concept mapping

Group concept mapping (GCM) is a mixed methods approach which can capture and structure recipients’ experiences of living with an LVAD. Cluster maps and the rating of generated statements facilitates the identification of key concepts, important domains and statements within each cluster [25, 26]. This structured method of mapping statements from the GCM exercises onto a conceptual framework can be used to identify suitable PROMs for use in clinical practice or research. It can also facilitate PROM development or refinement [27-29]. Future qualitative interviews will be used to explore identified domains in depth, and to facilitate further development and refinement of the conceptual framework [19]. The GCM approach recommended by Kane and Trochim (2007) was used. In the UK LVAD implantation is done in national heart transplant centres which cover a very large geographical area. Data were collected and analysed using the GroupwisdomTM online platform and concept mapping software [25, 26, 30]. Using an online platform allowed us to reach a wider range of LVAD recipients dispersed over this large geographical location. This was especially important as LVAD recipients who have had the implant for any length of time, and without complications infrequently attend clinic appointments, and therefore were less likely to engage with face-to-face GCM discussions. This was also important in order to accommodate COVID restrictions. Participants who consented to take part were given a unique ID, password and link to the GroupwisdomTM concept mapping website [30]. The GCM has three stages and participants were sent a link to activities at each stage. Each activity was completed before moving onto the next stage. Participants were sent a reminder if they had not accessed the activity within two weeks of being sent the link.

Stage 1. Statement generation

Participants were asked to respond to the prompt ‘Life with an LVAD means…….’. Participants generated statements which reflected their experiences in response to the prompt. Once completed, statements from all participants were aggregated and used in the next stage. If more than one idea was identified within a statement, it was split into separate statements. Duplicate ideas were combined or deleted, and statements were checked for literacy and spelling while trying to maintain the participant’s voice.

Stage 2. Sorting

Participants reviewed the aggregated list and individually sorted statements into thematic groups based on their experience. They labelled the groups based on their perceptions of the thematic content of the group and its meaning to them. This sorting exercise underpins the structure of the cluster analysis.

Stage 3. Rating

In the final stage, participants rated each statement for relevance to them, frequency, and how important they thought the statement was. Rating questions and scores included: Relevance–“Read each statement and tell us how much you feel this statement reflects your own experience?” 1 = Not at all; 2 = Sometimes my experience; 3 = Definitely my experience. Frequency–“How often do you feel like this statement?” 1 = Never; 2 = Sometimes; 3 = Frequently; 4 = All of the time. Importance–“How important is this statement to you?” 1 = Not important; 2 = Important; 3 = Very important. The GCM software allows you to identify the comparative importance, relevance and frequency of each cluster, as well as the statements within the cluster. Participants’ scores are averaged for individual statements and then these are averaged across the cluster. This provided a method for prioritising and structuring items, domains and general concepts based on participants preferences [31].

Data analysis

GroupwisdomTM concept mapping software was used to analyse the relationships and commonalities between participants’ responses to the sorting activity [30]. Non-metric multidimensional scaling (MDS) and hierarchical cluster analysis were applied to the data to produce visual representations as point and cluster maps. Full methodological details can be found elsewhere [25-27]. Data analysis consisted of two stages: First, MDS with a two-dimensional solution estimated the relationships (distant and proximal) generated from the summed similarity matrix created from participants’ choices in stage two [25, 30]. Statements frequently grouped together are located proximally, while less frequently grouped statements are distal to each other. The stress index is a goodness-of-fit statistic and a lower value indicates that the two dimensional x-y configuration is not random, and there is agreement between the final representation and the original similarity matrix [25, 27]. Secondly, utilizing the MDS x-y configuration, an agglomerative hierarchical cluster analysis uses Ward’s minimum variance method to optimise cluster merging [25, 30]. Cluster maps produce graphical representations of the similarities and inter-relationships between the domains and statements [27]. There can be as many clusters as statements; therefore, the agglomerative method successively merges statements and clusters. The GCM software allows each merged cluster solution to be reviewed after each iteration. A decision was made on whether the amalgamated content was appropriate, and the range of clusters optimised identifiable distinct groups with relevant thematic content. Each merger was labelled using agree (with the merger), tentative and disagree. The point at which disagree was the most likely option was used as a stopping point. This approach is recommended within the concept mapping literature [25-27].

Public and patient involvement

A patient and public advisory group with experience of living with an LVAD were consulted throughout the study. The group worked with AS to co-create the participant information documents, GCM prompt and wording of the rating questions, as well as iteratively assisting with the design of the GCM platform. They also advised on networking, recruitment and dissemination strategies. SG was an integral part of this group and acted as a patient research partner throughout the study.

Results

Participants

Eighteen LVAD recipients consented to take part in the GCM exercise. Four participants did not complete the GCM (reasons for non-completion included: health issues that prevented participation (n = 1), difficulty accessing the online format (n = 1) and reasons unknown (n = 2). The participant who struggled with the online format took part in subsequent qualitative interviews. One participant died (but had completed all but one rating question), as data were anonymised, their data were included in the results. The number of participants who completed the GCM was within recommended limits (n = 10–40) [26]. The median age of participants was 63 (range 40 to 72) years and the median length of time living with an LVAD was 25 months (range 1 to 86 months). A total of 101 statements were generated after reviewing for literacy, conceptual redundancy and duplication.

Points map

MDS analysis produced an overall stress index value of 0.32 after 16 iterations. This falls within the expected reference values (0.21 and 0.39) [26, 32]. Points generated from the x-y plots are shown on the points map (Fig 1A) [26].
Fig 1

Points map with overlay of nine cluster solution.

a. Points maps are visual representations of the two-dimensional solution generated from the similarity matrix created from participants choices in stage 2. Frequently grouped statements are located proximally while less frequently grouped statements are distal to each other. b. Cluster maps are visual representations of the hierarchical cluster analysis solution, and represent similarities and inter-relationships between the domains and items. Large clusters represent broader concepts, whereas smaller clusters represent more narrowly focused homogenous domains.

Points map with overlay of nine cluster solution.

a. Points maps are visual representations of the two-dimensional solution generated from the similarity matrix created from participants choices in stage 2. Frequently grouped statements are located proximally while less frequently grouped statements are distal to each other. b. Cluster maps are visual representations of the hierarchical cluster analysis solution, and represent similarities and inter-relationships between the domains and items. Large clusters represent broader concepts, whereas smaller clusters represent more narrowly focused homogenous domains.

Hierarchical cluster solution

A nine-cluster solution offered the best range of identifiable and interpretable distinct groups after reviewing a range of clusters (16 to 4 clusters). The cluster concept map represents the overlying hierarchical cluster analysis results onto the points map (Fig 1B). Cluster labels were generated by reviewing the thematic content of each cluster and labels used by participants.

Cluster descriptions

Activities

Activities consisted of five statements referring to types of activities that participants were able to do since receiving the LVAD. Statements relating to mobility had the highest scores for importance (2.00).

Partner and family support

Five statements related to participants’ feelings about their dependency on family/carers for practical and emotional support, and appreciation for that support. The highest rated statements related to gratitude for family support (2.44) and the need to rely on partner/carer for help with dressings (2.13).

Travel

Five statements related to travel, the need to be organised (2.25), and anxieties around security and available care. The need to be organised with the equipment while travelling (2.25) was also scored high for importance.

Mental wellbeing

Eleven statements were included in this cluster relating to issues around the impact of life changing surgery on body image and lifestyle, and difficulties adjusting to the LVAD. Highest rated statements for importance included the impact on mental health of having to come to terms with LVAD restrictions on everyday life (2.22), awareness of mortality (2.11), and challenges with mental health (2.00).

LVAD challenges

Seven statements were included in this cluster and they related to the adjustments required while learning to live with the LVAD, and other peoples’ reactions to the equipment. Over 50% (n = 5) of these statements were rated high for relevance, three were rated high for importance including trying to be positive while adjusting to the LVAD (2.33), being more mindful of your body (2.33), and the challenges of adjusting to a new way of life (2.22).

Equipment and clothing

This was the second largest cluster (16 statements) relating to equipment and batteries, dressings and drivelines, and trying to find suitable clothing to wear with the equipment. Nearly 60% of the statements (n = 10) were rated two or higher for importance. Some of the highest rated statements related to finding clothing solutions (2.22), issues with the bags, batteries and controller, the need to be organised with the batteries (2.33), the discipline required to deal with dressings (2.33), and difficulties associated with showering and bathing (2.33).

Physical and cognitive limitations

This was the third largest cluster with 13 statements relating to residual difficulties such as cognitive and memory problems, fatigue, and mobility problems. Nearly 70% (n = 9) of the statements were rated two or higher for importance including some of the highest scores overall relating to fatigue (2.67), and mobility issues (2.50). Other statements were related to not being able to work because of mobility (2.44), limited physical ability (2.44) and mental capacity (2.22).

LVAD restrictions

Eight statements relating to the restrictions imposed on their activities (2.22) and associated with the equipment (2.33). References to lack of spontaneity because of the need to be organised with the equipment (2.33), impact on everyday activities such as shopping (2.22) and worries about getting the equipment wet (2.33) were some of the highest rated statements for importance.

LVAD positives

LVAD Positives had 31 statements associated with the life-saving aspects and positive impacts from the LVAD, and feelings of gratitude in relation to receiving the LVAD. Over 80% (n = 27) of the statements were rated high or very high for importance. These included references to the life-saving aspects of the LVAD (2.67), gratitude to the clinical staff (2.67) and being able to have the LVAD, improvements in health and its impact on HRQoL (2.44) and ability to engage in family activities (2.38). Bridging values ranging from 0 to 1 (Fig 2 and Table 1) and indicate the extent to which sorting responses by participants were similar in stage 2. Higher values suggest a statement is more heterogeneous and has links to broader concepts (Fig 2A). While lower values closer to 0 suggest statements were more homogeneous and more frequently sorted together. These statements can be “anchors” for other statements close to them within the cluster (Fig 2B) [26]. Spanning Values (Fig 2) represent how frequently statements were sorted together, a thicker line demonstrates that other statements were frequently sorted with the selected statement (100 ‘I have to look after my equipment as my life relies on it’ and 27 ‘Without my LVAD I wouldn’t be here’).
Fig 2

Bridging values for statements.

Table 1

Cluster descriptions and examples of included statements.

Clusters with examples of statementsMean Scores
Point IDCluster (Total no of statements)Bridging Values (0–1)Rating Importance (1 to 3)Rating Frequency (1 to 4)Rating Relevance (1 to 3)
1) Activities (5) 0.56 (0.04)* 1.37 (0.35)* 1.48 (0.49)* 1.58 (0.36)*
1I can still play golf using my buggy0.531.001.001.18
82I can now walk without any problem0.542.002.402.09
2) Partner/Family support (5) 0.57 (0.09)* 2.02 (0.39)* 2.36 (0.62)* 2.06 (0.41)*
38My partner/carer does my dressings and gives me loads of support.0.622.132.602.27
45I no longer have my personal freedom because I need someone with me0.521.501.701.67
3) Travel (5) 0.75 (0.12)* 1.88 (0.28)* 2.25 (0.47)* 2.26 (0.22)*
54It has made me more organized when travelling as the equipment is very important for life now1.002.252.672.33
64I am glad I can continue to travel despite the lack of understanding as to what an LVAD is by security staff!0.681.892.102.09
4) Mental Wellbeing (11) 0.32 (0.05)* 1.79 (0.33)* 2.16 (0.45)* 1.92 (0.33)*
17I have had challenges with my mental health0.282.002.331.83
69I was extremely grateful at first, but as time goes by, I feel like I am existing and not living anymore0.291.631.801.58
5) LVAD challenges (7) 0.46 (0.12)* 1.97 (0.30)* 2.47 (0.60)* 2.27 (0.37)*
8I am adjusting to a new way of living0.512.222.672.67
16Other people’s reaction to the kit can sometimes be upsetting, but I have found ways round that, and my own mental picture of myself.0.391.561.601.64
6) Equipment and clothing (16) 0.38 (0.13)* 2.01 (0.28)* 2.67 (0.43)* 2.41 (0.33)*
5You have to try to find clothing solutions to carry all the equipment.0.222.222.802.50
58I am used to the batteries and controller now.0.492.223.402.82
7) Physical/cognitive limitations (13) 0.50 (0.16)* 2.19 (0.31)* 2.81 (0.45)* 2.25 (0.32)*
24I am unable to work because of a lack of energy0.382.333.102.58
70I sometimes struggle to remember things0.292.002.402.27
8) LVAD restrictions (8) 0.35 (0.09)* 2.11 (0.21)* 2.66 (0.35)* 2.32 (0.15)*
42I have to think about what I need when I leave home, even for 10 minutes.0.292.332.902.27
77There are restrictions to normal activities.0.302.223.102.55
9) LVAD Positives (31) 0.22 (0.18)* 2.21 (0.34)* 2.84 (0.47)* 2.44 (0.39)*
28I am happy with my LVAD.0.112.333.302.67
53The LVAD saved my life.0.042.443.332.82

*Averaged scores across the cluster (SD)

*Averaged scores across the cluster (SD) Some examples of descriptions, bridging values and content of the clusters can be seen in Table 1. Overall rating scores for the clusters and examples of individual statements within each cluster.

Stage 3. Rating of individual statements

Rating of the individual statements can be used to identify the relative importance of clusters and individual statements for LVAD recipients. Average scores for clusters and statements (Table 1), allow comparisons across and within clusters for the different rating scales. Pattern match figures (Fig 3) provide visual comparisons of average cluster scores across the different rating variables.
Fig 3

Average rating scores pattern match by cluster.

Average cluster scores are shown at the top and bottom of the ladder. Clusters are positioned on the vertical axis and vertical lines represent each rating variable. Horizontal lines join the cluster scores within each rating variable for comparison. This shows the relative importance of clusters for recipients.

Average rating scores pattern match by cluster.

Average cluster scores are shown at the top and bottom of the ladder. Clusters are positioned on the vertical axis and vertical lines represent each rating variable. Horizontal lines join the cluster scores within each rating variable for comparison. This shows the relative importance of clusters for recipients.

Conceptual framework

Using information provided by the GCM enabled us to review the content and scoring of individual clusters and statements, and facilitated the development of a conceptual framework for the important items and domains [19, 27]. This conceptual framework can be used to ensure that selection of patient reported outcomes used in clinical practice or research reflect the concerns of LVAD recipients.(Fig 4) Individual statements can be mapped to items within PROMs to ensure they are capturing the issues that are considered important for recipients.
Fig 4

LVAD HRQoL conceptual framework.

Conceptual framework based on clusters and statements within identifying key domains and items that are important to LVAD recipients.

LVAD HRQoL conceptual framework.

Conceptual framework based on clusters and statements within identifying key domains and items that are important to LVAD recipients.

Discussion

Using GCM provided a structured approach to the development of a conceptual framework, allowing us to identify the relative importance of the different domains and items for LVAD recipients [19, 25]. A clear conceptual framework should underpin PROM development and evaluation if they are to represent the lived experiences of LVAD recipients [33]. Having a clear concept is important for use in clinical trials, design evolution or research as it places the patient and their experience at the heart of clinical trials, healthcare and research [33]. GCM has several advantages when developing or identifying suitable PROMs for use with this group. It provides a clearly defined method of eliciting the content required for any PROMs. It also allows identification of domains or items that are relatively unimportant to participants and this is useful when trying to minimise irrelevant content [28]. The LVAD positives cluster was rated highest across all the rating values and was viewed as important and relevant; the bridging values suggest this is a homogenous set of items which reflect the need to make this a focus for any PROMs being used with LVAD recipients. Recipients’ positive experiences with the LVAD is a valuable insight as positive experiences can sometimes be overlooked by clinicians who may inadvertently concentrate on the negative impacts of an intervention. Identifying LVAD recipients whose experiences do not reflect this positive stance may also indicate that clinical intervention or additional support is required. It might also be useful to monitor whether positive experiences increase or decrease over time as recipients adapt to life with an LVAD. Some participants were still experiencing physical and cognitive challenges as demonstrated by cluster seven which was scored second highest for importance. This was one of the largest clusters and covered residual issues such as cognitive function, fatigue and limitations in physical capacity. This suggests that while the LVAD does have a positive impact there are still some outstanding issues that might need to be addressed. Not surprisingly, Equipment and Clothing, and LVAD restrictions were also scored high for importance. Given the unique issues that LVAD recipients experience, this reflects the importance of ensuring any PROMs used with this group reflect these experiences, otherwise the full extent of improvements or deterioration in HRQoL and adjustment to life with an LVAD will not be captured. Individual statements were also highlighted as important within the clusters. Within the LVAD positives cluster, one of the highest scoring statements was “I feel grateful that it has prolonged my life”. One of the highest scoring statements for equipment was around the need to be disciplined with the equipment “Discipline is required for dressings, battery management, showering, logbook completing. My life depends on this discipline”. Having access to this detailed data can reveal the relative importance of experiences, and these issues would need to be reflected in any PROMs used. These insights can facilitate the generation of outcomes that matter to recipients and facilitate further in-depth exploration through qualitative interviews. While it could be argued that the sample completing the exercise was small and the opportunity for the development of the issues in depth is limited, the number completing the GCM is within the recommended range for concept mapping studies, and reflects the small number of LVAD recipients [26]. Using the online software to remotely capture their experiences allowed us to recruit participants from a wide geographical area. In the UK, LVAD implant services are few and dispersed across the country. Consequently, patients often have to travel long distances to attend hospital appointments. Access to this online format is especially important in this post-COVID era when many hospital consultations have moved online. One of the limitations of this approach is that it does require a certain degree of computer and language literacy for participants to take part; this was evident as one participant struggled to access the site even with support from the research team. However, this participant was offered the opportunity to take part in qualitative interviews so their experiences can still inform our understanding of their issues. Limiting the language to English may mean additional cultural perspectives may have been lost. One limitation of the current study is the potential for gender bias as no women agreed to take part in this part of the research programme. This maybe a reflection of the small proportion of women (<20%) who receive an LVAD [34]. However, female participants agreed to take part in the qualitative interviews and we will explore whether female insights differ substantially from their male counterparts. One of the strengths of this study is the involvement of the PPI group who have contributed throughout the study providing initial guidance on the need for a specific PROM, to the design and development of the online GCM process, providing unique input and insights at different stages of the project. One of the group (SG) has acted as a co-investigator throughout the project. The results of the GCM can be used to develop a deeper understanding of the issues for LVAD recipients. The domains and statements were also used to develop a topic guide for qualitative interviews with LVAD recipients. Relying on literature alone to develop a topic guide might have missed the personal and unique nature of LVAD recipients’ experiences shared during this GCM process.

Conclusion

The online GCM exercise has produced a conceptual map of key areas that are important to LVAD recipients. The GCM will support the development of semi-structured qualitative interviews to allow in-depth discussion of the key points raised by participants. Together, this information will support prioritised patient reported outcome measurement in future research, design evolution and clinical practice with LVAD recipients.

Importance point rating map.

Points map showing which statements were considered important by LVAD recipients. Scoring Importance: 1 = Not important; 2 = Important; 3 = Very important. (TIF) Click here for additional data file.

Relevance points rating map.

Points map showing which statements most reflected recipients’ experiences. Scoring for relevance: 1 = Not at all; 2 = Sometimes my experience; 3 = Definitely my experience. (TIF) Click here for additional data file.

Frequency points rating map.

Points map showing which statements recipients thought frequently reflected their experiences. Scoring for Frequency: 1 = Never; 2 = Sometimes; 3 = Frequently; 4 = All of the time. (TIF) Click here for additional data file. (XLSX) Click here for additional data file. (PDF) Click here for additional data file. 8 Mar 2022
PONE-D-21-38323
Living with a Left Ventricular Assist Device: capturing recipients experiences using group concept mapping software
PLOS ONE Dear Dr. Slade, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.
 
Two reviewers have read your work. Please consider submitting a revised version of your work based on comments of reviewers. Please submit your revised manuscript by Apr 22 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Salil Deo Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf  and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information. 3. Thank you for stating the following in the Funding Section of your manuscript: “This work was supported by funding from the British Heart Foundation (PG/18/58/33944). This paper presents independent research supported by the National Institute of Health Research Birmingham Biomedical Research Centre at the University Hospitals Birmingham National Health Service Foundation Trust and the University of Birmingham. The study funders did not have any role in the study design; the collection, analysis, and interpretation of the data; the writing of the report; or the decision to submit the article for publication. ALS was supported by funding from: The British Heart Foundation, National Institute for Health Research Invention for Innovation, Medical Research Council, National Institute for Health Research MedTech and INvitro diagnostics Co-operative–Trauma management, National Institute for Health Research Clinical Research Network; National Institute For Health Research  Birmingham Biomedical Research Centre and National Institute For Health Research Surgical Reconstruction and Microbiology Research Centre at the University of Birmingham and University Hospitals Birmingham National Health Service Foundation Trust outside the submitted work. MC is a National Institute for Health Research Senior Investigator and receives funding from the National Institute for Health Research Birmingham Biomedical Research Centre, the National Institute for Health Research Surgical Reconstruction and Microbiology Research Centre and National Institute for Health Research Applied Research Collaboration West Midlands at the at the University of Birmingham and University Hospitals Birmingham National Health Service Foundation Trust, Health Data Research United Kingdom, Innovate United Kingdom (part of United Kingdom Research and Innovation), Macmillan Cancer Support, Health Foundation, UCB Pharma and GSK. MC has received personal fees from Astellas, Takeda, Merck, Daiichi Sankyo, Glaukos, GlaxoSmithKline and the Patient-Centred Outcomes Research Institute (PCORI) outside the submitted work. DL has received investigator-initiated educational grants (paid to the institution) from Bristol-Myers Squibb (BMS) and personal fees from Boehringer Ingeheim, Bayer, BMS/Pfizer, and Daiichi-Sankyo outside the submitted work.” We note that you have provided additional information within the Funding Section that is not currently declared in your Funding Statement. Please note that funding information should not appear in other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: “This work was supported by funding from the British Heart Foundation (PG/18/58/33944). This paper presents independent research supported by the National Institute of Health Research Birmingham Biomedical Research Centre at the University Hospitals Birmingham National Health Service Foundation Trust and the University of Birmingham.” Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 4. Please upload a new copy of Figure 1 as the detail is not clear. Please follow the link for more information: " ext-link-type="uri" xlink:type="simple">https://blogs.plos.org/plos/2019/06/looking-good-tips-for-creating-your-plos-figures-graphics/" https://blogs.plos.org/plos/2019/06/looking-good-tips-for-creating-your-plos-figures-graphics/" 5. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability. Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized. Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access. We will update your Data Availability statement to reflect the information you provide in your cover letter. 6. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments (if provided): Please consider revising your work based on the reviewer's comments provided. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The authors present the results of a quite sophisticated study of a small group (18) of LVAD recipients who are being followed at one of the Heart Failure Canters in UK. The study targets eliciting and evaluating personal experience of living with an LVAD using Concept Group Mapping (GCM) approach. The participants were first asked to generate statements reflecting such experience in several categories. Such statements were then grouped, and the participants have rated those in three categories of relevance, frequency, and importance. All responses were then put through quite complex statistical analysis which evaluated several clusters and allowed comparisons between the clusters and inside each cluster using scores generated for such comparisons. The authors claim that this approach offers important advantage to other Patient Related Outcome Measures( PROMs) often used in evaluating outcomes of LVAD implantation or other life-modifying procedures. The main such advantage comes from the fact that the data are generated by allowing the actual recipients of the treatment ( such as LVAD) to make statements describing different aspects of their life with the LVAD in their own words rather than answer prepared questions. There is data in the literature that the most accurate information regarding life with the LVAD comes from those who live with the LVAD. In addition, GCM approach has been successfully applied for concept generation and evaluation in the past. It does seem to have allowed the authors to benefit from working with the data generated by a small number of participants. Overall, the findings of the study do contribute some additional information as to is important to the LVAD recipients at which stage of their with the LVAD. However, it is hard to imagine that this information by itself would influence the direction of development of the new generations of LVADs. Reviewer #2: The implantation of a Left Ventricular Assist Device (LVAD) changes the life of both the patient and their family. Despite clinical improvement in most cases, the user is faced with equipment that imposes restrictions and changes in their image as a result of the surgery and the driveline. Beyond the usual knowledge about LVAD functioning and device-associated complications (such as infections, bleeding, thrombosis, or hemolysis), the attending physician should try to address the patient's feelings about their device. This manuscript does an excellent job of putting the user experience with LVADs at the center of the research, making it possible to identify domains and items that can be used in the development of Patient-Reported Outcome Measures (PROMs) in future research. Using the online Group Concept Mapping (GCM) software to identify these domains and items was also a great success for the authors, as it allowed people using LVADs who lived in different geographic regions to collaborate with the research. In addition to allowing the creation of statements, the GCM allows the research participant to sort and rate them, making it possible to identify what should be prioritized in future PROMS. Despite the good work done by the investigation team, we were able to list some recommendations to improve the understanding of the information generated by the research. Figures and Tables: · Figure 1A: Although the figure looks solid, the language of its legend is not clear, making it difficult to understand. I advise you to put some details on the interpretation of the legend as found in Line 209: "Statements frequently grouped together are located proximally, while less frequently grouped 210 statements are distal to each other." · Figure 1B: This figure represents the clusters well; however, we suggest that each cluster had a different color to facilitate visualization. It’s interesting to add the description about the size of the clusters found between lines 258 - 260. · Figure 2: This figure is not clear. We suggest detailing a little more about bridging values in the legend (similar between lines 319 and 325). Also, the lines have similar colors, but different thicknesses, so you could be specified what each line thickness is and there are different color points without explanation. · Figure 3: This figure is the most important, because it shows the importance, frequency, and relevance of each cluster. My suggestion is to put each cluster and line with different colors. · ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Yakov Elgudin, MD, PhD Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
8 Jul 2022 Reference: PONE-D-21-38323 Dear Dr Deo, Thank you for your positive review of our paper entitled “Living with a Left Ventricular Assist Device: capturing recipient’s experiences using group concept mapping software” and the opportunity to revise the manuscript. We have provided a point-by-point response to the Reviewers’ comments (see ‘Response to Reviewers” document). Amendments have been made in the manuscript and tracked for ease of review. Responses to additional changes requested by the Editorial team are provided below. Financial disclosure: This has been removed from the manuscript and is provided below. This work was funded by the British Heart Foundation (PG/18/58/33944). The study funders did not have any role in the study design, the collection, analysis, or interpretation of the data, the writing of the report, or the decision to submit the article for publication. ALS was funded for work on this project by the The British Heart Foundation. ALS also reports support from National Institute for Health Research Invention for Innovation, Medical Research Council, National Institute for Health Research MedTech and INvitro diagnostics Co-operative–Trauma management, National Institute for Health Research Clinical Research Network; National Institute For Health Research Birmingham Biomedical Research Centre and National Institute For Health Research Surgical Reconstruction and Microbiology Research Centre at the University of Birmingham and University Hospitals Birmingham National Health Service Foundation Trust outside the submitted work. MC is a National Institute for Health Research Senior Investigator and receives funding from the National Institute for Health Research Birmingham Biomedical Research Centre, the National Institute for Health Research Surgical Reconstruction and Microbiology Research Centre and National Institute for Health Research Applied Research Collaboration West Midlands at the at the University of Birmingham and University Hospitals Birmingham National Health Service Foundation Trust, Health Data Research United Kingdom, Innovate United Kingdom (part of United Kingdom Research and Innovation), Macmillan Cancer Support, Health Foundation, UCB Pharma and GSK. MC has received personal fees from Astellas, Takeda, Merck, Daiichi Sankyo, Glaukos, GlaxoSmithKline and the Patient-Centred Outcomes Research Institute (PCORI) outside the submitted work. DAL has received investigator-initiated educational grants from Bristol-Myers Squibb (BMS), has been a speaker for Bayer, Boehringer Ingeheim, and BMS/Pfizer and has consulted for BMS, and Boehringer Ingelheim. HSL declares no funding conflict and honoraria from Abbott. DQ declares no funding conflict and honoraria from Abbott. MoH, SG, MSH, PD LM declare no funding conflicts All authors report no conflicts of interest. Figure 1 has been recoloured as suggested by Reviewer 2, and exported from GIMP as a tif, and it has been checked by PACE as suggested on the website. Consent procedures: More information has been added to the methods section on the consent procedures (see page 26). Table 1 has been reformatted although this was not requested, we feel the current format is easier to read (see page 17). Data availability statement: Data is now provided as a supplementary file in an excel format. We have included the statement id but not the actual text as discussed before this is being used to develop a patient reported outcome measure as part of a larger substantive piece of work which is ongoing. It is hoped that we will be published next year (2023). We have included the similarity matrix data and distance matrix data which underpins the hierarchical cluster analysis and multi-dimensional scaling as well as the rating scale scores for frequency, importance and relevance. There are no changes or retractions for the reference list. We hope the revisions to the manuscript meet with your approval and we look forward to hearing from you. Your sincerely Dr Anita Slade Email: a.l.slade@bham.ac.uk Response to Reviewers’ comments Reviewer 1. We would like to thank the Reviewer for their positive comments. Reviewer #1: The authors present the results of a quite sophisticated study of a small group (18) of LVAD recipients who are being followed at one of the Heart Failure Canters in UK. The study targets eliciting and evaluating personal experience of living with an LVAD using Concept Group Mapping (GCM) approach. The participants were first asked to generate statements reflecting such experience in several categories. Such statements were then grouped, and the participants have rated those in three categories of relevance, frequency, and importance. All responses were then put through quite complex statistical analysis which evaluated several clusters and allowed comparisons between the clusters and inside each cluster using scores generated for such comparisons. The authors claim that this approach offers important advantage to other Patient Related Outcome Measures (PROMs) often used in evaluating outcomes of LVAD implantation or other life-modifying procedures. The main such advantage comes from the fact that the data are generated by allowing the actual recipients of the treatment (such as LVAD) to make statements describing different aspects of their life with the LVAD in their own words rather than answer prepared questions. There is data in the literature that the most accurate information regarding life with the LVAD comes from those who live with the LVAD. In addition, GCM approach has been successfully applied for concept generation and evaluation in the past. It does seem to have allowed the authors to benefit from working with the data generated by a small number of participants. Overall, the findings of the study do contribute some additional information as to is important to the LVAD recipients at which stage of their with the LVAD. However, it is hard to imagine that this information by itself would influence the direction of development of the new generations of LVADs. Response to reviewer 1. Thank you for your positive review of our paper. We agree that working with this group of LVAD recipients has given us an overview of their experiences of living with an LVAD, and their positive and negative experiences across a range of issues related to living with the LVAD. We agree that this part of the project itself will not influence the development of a new generation of LVADs but we hope some of the issues highlighted in the equipment and clothing section in particular may help us identify potential solutions with further research in the future. This project is also part of a larger project which has included in-depth qualitative interviews using GCM as a guide for semi-structured interviews. This has allowed us to explore the issues related to living with the LVAD in more depth. We hope that future development of patient reported outcome measures that are specific to LVAD recipients based on the GCM and interviews may address some of their concerns as well as supporting research and development of design evolutions. Reviewer 2 Reviewer #2: The implantation of a Left Ventricular Assist Device (LVAD) changes the life of both the patient and their family. Despite clinical improvement in most cases, the user is faced with equipment that imposes restrictions and changes in their image as a result of the surgery and the driveline. Beyond the usual knowledge about LVAD functioning and device-associated complications (such as infections, bleeding, thrombosis, or hemolysis), the attending physician should try to address the patient's feelings about their device. This manuscript does an excellent job of putting the user experience with LVADs at the center of the research, making it possible to identify domains and items that can be used in the development of Patient-Reported Outcome Measures (PROMs) in future research. Using the online Group Concept Mapping (GCM) software to identify these domains and items was also a great success for the authors, as it allowed people using LVADs who lived in different geographic regions to collaborate with the research. In addition to allowing the creation of statements, the GCM allows the research participant to sort and rate them, making it possible to identify what should be prioritized in future PROMS. Response to Reviewer 2 We would like to thank the Reviewer for their positive comments. Despite the good work done by the investigation team, we were able to list some recommendations to improve the understanding of the information generated by the research. Figures and Tables: · Figure 1A: Although the figure looks solid, the language of its legend is not clear, making it difficult to understand. I advise you to put some details on the interpretation of the legend as found in Line 209: "Statements frequently grouped together are located proximally, while less frequently grouped 210 statements are distal to each other." Response to Reviewer 2 We have revisited all the figures and recoloured them to help with the differentiation between the different clusters, and added legends into the text as suggested. We have also included additional explanations in Figure 2 which we hope will make it easier to interpret. Unfortunately, because of the way the bridging and anchor statements figures are generated (within the GCM software) it has not been possible to recolour them. We tried to make them clearer using the online suggestions from PLOS one. Fig 1. Legend Legend Fig 1a Points maps are visual representations of the two-dimensional solution generated from the similarity matrix created from participants choices in stage 2. Frequently grouped statements are located proximally while less frequently grouped statements are distal to each other. (see page 12) Figure 1B: This figure represents the clusters well; however, we suggest that each cluster had a different color to facilitate visualization. It’s interesting to add the description about the size of the clusters found between lines 258 - 260. Legend Fig 1b Cluster maps are visual representations of the hierarchical cluster analysis solution and represent similarities and inter-relationships between the domains and items. Large clusters represent broader concepts, whereas smaller clusters represent more narrowly focused homogenous domains. (see page 12) Figure 2: This figure is not clear. We suggest detailing a little more about bridging values in the legend (similar between lines 319 and 325). Also, the lines have similar colors, but different thicknesses, so you could be specified what each line thickness is and there are different color points without explanation. We have included additional explanations in Figure 2 which we hope will make it easier to interpret. Unfortunately, because of the way the bridging and anchor statements figures are generated (within the GCM software) it has not been possible to recolour them. We tried to make them clearer using the online suggestions from PLOS one. Figure 3: This figure is the most important, because it shows the importance, frequency, and relevance of each cluster. My suggestion is to put each cluster and line with different colors. Response to Reviewer 2 We have revisited all the figures and recoloured them to help with the differentiation between the different clusters, and added legends into the text as suggested. Figure 2: This figure is not clear. We suggest detailing a little more about bridging values in the legend (similar between lines 319 and 325). Also, the lines have similar colors, but different thicknesses, so you could be specified what each line thickness is and there are different color points without explanation. Response to Reviewer 2 Thank you for your comments we have added some explanation of the different thicknesses and what the different colour points mean to the figure. Additional information has been added to the legend in the manuscript. Fig 2 legend Bridging values ranging from 0 to 1 (Fig 2. Table 1) and indicate the extent to which sorting responses by participants were similar in stage 2. Higher values suggest a statement is more heterogeneous and has links to broader concepts (Fig 2a). While lower values closer to 0 suggest statements were more homogeneous and more frequently sorted together. These statements can be “anchors” for other statements close to them within the cluster (Fig 2b).[28] Spanning Values (Fig 2) represent how frequently statements were sorted together, a thicker line demonstrates that other statements were frequently sorted with the selected statement (100 ‘I have to look after my equipment as my life relies on it’ and 27 ‘Without my LVAD I wouldn’t be here’). Figure 3: This figure is the most important, because it shows the importance, frequency, and relevance of each cluster. My suggestion is to put each cluster and line with different colors. Response to Reviewer 2 Thank you for your comments, this has been recoloured to match the cluster map. Submitted filename: Response to reviewers 1 and 2 14 04 22 PONE-D-21-38323.docx Click here for additional data file. 3 Aug 2022 Living with a Left Ventricular Assist Device: capturing recipients experiences using group concept mapping softwareo:p/o:p PONE-D-21-38323R1 Dear Dr. Slade, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Salil Deo Academic Editor PLOS ONE Additional Editor Comments (optional): Thank you very much for submitting your work to PLOS ONE. We are delighted to inform you that your paper has been accepted for publication. Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #2: The authors adequately responded to the reviewers' questions. I suggest that the article be accepted for publication. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #2: No ********** 6 Sep 2022 PONE-D-21-38323R1 Living with a Left Ventricular Assist Device: capturing recipients experiences using group concept mapping software Dear Dr. Slade: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Salil Deo Academic Editor PLOS ONE
  27 in total

Review 1.  Quality and rigor of the concept mapping methodology: a pooled study analysis.

Authors:  Scott R Rosas; Mary Kane
Journal:  Eval Program Plann       Date:  2011-10-12

2.  Patient-Reported Outcomes in Chronic Heart Failure: Applicability for Regulatory Approval.

Authors:  Mitchell A Psotka; Robyn von Maltzahn; Milena Anatchkova; Irene Agodoa; Dina Chau; Fady I Malik; Donald L Patrick; John A Spertus; Ingela Wiklund; John R Teerlink
Journal:  JACC Heart Fail       Date:  2016-07-06       Impact factor: 12.035

Review 3.  Bridge to transplantation: current outcomes.

Authors:  Sanjeev Aggarwal; Francis D Pagani
Journal:  J Card Surg       Date:  2010-02-18       Impact factor: 1.620

Review 4.  The use of concept mapping in measurement development and evaluation: Application and future directions.

Authors:  Scott R Rosas; John W Ridings
Journal:  Eval Program Plann       Date:  2016-08-28

5.  Global Public Health Burden of Heart Failure.

Authors:  Gianluigi Savarese; Lars H Lund
Journal:  Card Fail Rev       Date:  2017-04

6.  The impact of chronic heart failure on health-related quality of life data acquired in the baseline phase of the CARE-HF study.

Authors:  Melanie J Calvert; Nick Freemantle; John G F Cleland
Journal:  Eur J Heart Fail       Date:  2005-03-02       Impact factor: 15.534

7.  Patient-reported outcomes: conceptual issues.

Authors:  Margaret L Rothman; Philippe Beltran; Joseph C Cappelleri; Joseph Lipscomb; Bonnie Teschendorf
Journal:  Value Health       Date:  2007 Nov-Dec       Impact factor: 5.725

8.  Patient Reported Outcomes Measures (PROMS) in Cardiovascular Disease.

Authors:  Ran Kornowski
Journal:  Eur Heart J Qual Care Clin Outcomes       Date:  2021-08-09

9.  Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols: The SPIRIT-PRO Extension.

Authors:  Melanie Calvert; Derek Kyte; Rebecca Mercieca-Bebber; Anita Slade; An-Wen Chan; Madeleine T King; Amanda Hunn; Andrew Bottomley; Antoine Regnault; An-Wen Chan; Carolyn Ells; Daniel O'Connor; Dennis Revicki; Donald Patrick; Doug Altman; Ethan Basch; Galina Velikova; Gary Price; Heather Draper; Jane Blazeby; Jane Scott; Joanna Coast; Josephine Norquist; Julia Brown; Kirstie Haywood; Laura Lee Johnson; Lisa Campbell; Lori Frank; Maria von Hildebrand; Michael Brundage; Michael Palmer; Paul Kluetz; Richard Stephens; Robert M Golub; Sandra Mitchell; Trish Groves
Journal:  JAMA       Date:  2018-02-06       Impact factor: 56.272

10.  A comparison of three methods to generate a conceptual understanding of a disease based on the patients' perspective.

Authors:  Louise Humphrey; Thomas Willgoss; Andrew Trigg; Stephanie Meysner; Mary Kane; Sally Dickinson; Helen Kitchen
Journal:  J Patient Rep Outcomes       Date:  2017-12-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.